You can buy or sell Stryker and other stocks, options, ETFs, and crypto commission-free!
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. Read More The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
52 Week High
52 Week Low
Global Spine Biologics Industry Outlook, 2025 with Profiles of Key Players Including DePuy Synthes, Orthofix Medical, Stryker, and Zimmer Biomet
Dublin, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Spine Biologics Market: Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMark
$0.55 per share
$0.64 per share